A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection

NCT00605384 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Business Objectives Have Changed

Conditions

Chronic Hepatitis B

Interventions

DRUG: Entecavir + Tenofovir
DRUG: Adefovir + continuing Lamivudine

Sponsor

Bristol-Myers Squibb